2-Methylamino-3-nitro-5-(trifluoromethyl)pyridine, 97.0%, 100mg

3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)azetidine-3-carboxylic acid, 95%, 1g

3-((tert-Butoxycarbonyl)amino)-4-chlorobenzoic acid, 97%, 5g

tert-Butyl 2-amino-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate hydrochloride, 95%, 500mg

4-Bromo-1-ethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 100mg

1H-Pyrrole-2,5-dione, 3,4-di-1H-indol-3-yl-1-methyl-, 98%, 100mg

Ácido caprónico, mínimo 98%, para síntesis, 1L, envase de vidrio

N-(3-Aminopropyl)glycine Dihydrochloride, 95+%, 5g

1-Phenyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid, 95.0%, 100mg

2,4,6-Triisopropylbenzenesulfonohydrazide, 95.0%, 10g

2-Hydroxy-3-methoxy-5-nitrobenzaldehyde, 98.0%, 10g

tert-Butyl 8-hydroxy-5-azaspiro[3.5]nonane-5-carboxylate, 95.0%, 250mg

3-(Dimethylphosphono)-N-methylolpropionamide, 82.0%, 1g